MRE11 and colorectal carcinoma: In this study, by analyzing the prognostic value in RSCC and LSCRC, high expression of MRE11 was found to be a favorable factor for prognosis in LSCRC rather than RSCC, which underlines that the survival benefit of the high expression of MRE11 is not derived from any CRC location, but the LSCRC.